These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20848657)

  • 1. Development of a polymeric patch impregnated with naproxen as a model of transdermal sustained release system.
    Argemí A; Ellis JL; Saurina J; Tomasko DL
    J Pharm Sci; 2011 Mar; 100(3):992-1000. PubMed ID: 20848657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of a self-adhesive naproxen-loaded film prepared from a nanoparticle dispersion.
    Ganem-Quintanar A; Silva-Alvarez M; Alvarez-Román R; Casas-Alancaster N; Cázares-Delgadillo J; Quintanar-Guerrero D
    J Nanosci Nanotechnol; 2006; 6(9-10):3235-41. PubMed ID: 17048542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of liposomes on transdermal permeation of naproxen--in vitro studies.
    Szura D; Ozimek Ł; Przybyło M; Karłowicz-Bodalska K; Jaźwińska-Tarnawska E; Wiela-Hojeńska A; Han S
    Acta Pol Pharm; 2014; 71(1):145-51. PubMed ID: 24779203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems.
    Conforti A; Bertani S; Lussignoli S; Grigolini L; Terzi M; Lora S; Caliceti P; Marsilio F; Veronese FM
    J Pharm Pharmacol; 1996 May; 48(5):468-73. PubMed ID: 8799869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and in vitro evaluation of vinyl ether type polymeric prodrugs of ibuprofen, ketoprofen and naproxen.
    Babazadeh M
    Int J Pharm; 2008 May; 356(1-2):167-73. PubMed ID: 18289807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacyl glyceryl ester prodrugs for slow release in the skin: synthesis and in vitro degradation and absorption studies for naproxen derivatives.
    Thorsteinsson T; Másson M; Loftsson T; Haraldsson GG; Stefánsson E
    Pharmazie; 1999 Nov; 54(11):831-6. PubMed ID: 10603609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeation of naproxen from saturated solutions and commercial formulations through synthetic membranes.
    Farinha A; Toscano C; Campos R; Bica A; Hadgraft J
    Drug Dev Ind Pharm; 2003 Apr; 29(4):489-94. PubMed ID: 12737541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles.
    Rodrigues MR; Lanzarini CM; Ricci-Junior E
    Pharm Dev Technol; 2011 Feb; 16(1):12-21. PubMed ID: 20001271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs.
    Duarte AR; Costa MS; Simplício AL; Cardoso MM; Duarte CM
    Int J Pharm; 2006 Feb; 308(1-2):168-74. PubMed ID: 16368203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled Release of Lidocaine-Diclofenac Ionic Liquid Drug from Freeze-Thawed Gelatin/Poly(Vinyl Alcohol) Transdermal Patches.
    Maneewattanapinyo P; Yeesamun A; Watthana F; Panrat K; Pichayakorn W; Suksaeree J
    AAPS PharmSciTech; 2019 Oct; 20(8):322. PubMed ID: 31650263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, development, and optimization of polymeric based-colonic drug delivery system of naproxen.
    Sharma P; Chawla A; Pawar P
    ScientificWorldJournal; 2013; 2013():654829. PubMed ID: 24198725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
    Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
    Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ester prodrug-loaded electrospun cellulose acetate fiber mats as transdermal drug delivery systems.
    Wu XM; Branford-White CJ; Zhu LM; Chatterton NP; Yu DG
    J Mater Sci Mater Med; 2010 Aug; 21(8):2403-11. PubMed ID: 20499138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
    Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
    Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric protection of naproxen in a fixed-dose combination product produced by hot-melt co-extrusion.
    Vynckier AK; De Beer M; Monteyne T; Voorspoels J; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2015 Aug; 491(1-2):243-9. PubMed ID: 26068198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterisation of polyphosphazene-based controlled release systems for naproxen.
    Caliceti P; Lora S; Marsilio F; Veronese FM
    Farmaco; 1995 Dec; 50(12):867-74. PubMed ID: 8634078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged naproxen joint residence time after intra-articular injection of lipophilic solutions comprising a naproxen glycolamide ester prodrug in the rat.
    Thing M; Lu Y; Agårdh L; Larsen C; Ostergaard J; He W; Wu W; Larsen F; Larsen SW
    Int J Pharm; 2013 Jul; 451(1-2):34-40. PubMed ID: 23624087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations.
    Ustündağ Okur N; Apaydın S; Karabay Yavaşoğlu NÜ; Yavaşoğlu A; Karasulu HY
    Int J Pharm; 2011 Sep; 416(1):136-44. PubMed ID: 21723930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.